Cargando…
YAP/TAZ Activation as a Target for Treating Metastatic Cancer
Yes-Associated Protein (YAP) and Transcriptional Co-activator with PDZ-binding Motif (TAZ) have both emerged as important drivers of cancer progression and metastasis. YAP and TAZ are often upregulated or nuclear localized in aggressive human cancers. There is abundant experimental evidence demonstr...
Autores principales: | Warren, Janine S. A., Xiao, Yuxuan, Lamar, John M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923370/ https://www.ncbi.nlm.nih.gov/pubmed/29642615 http://dx.doi.org/10.3390/cancers10040115 |
Ejemplares similares
-
SRC tyrosine kinase activates the YAP/TAZ axis and thereby drives tumor growth and metastasis
por: Lamar, John M., et al.
Publicado: (2019) -
Epithelioid Hemangioendothelioma as a Model of YAP/TAZ-Driven Cancer: Insights from a Rare Fusion Sarcoma
por: Lamar, John M., et al.
Publicado: (2018) -
The role of YAP/TAZ activity in cancer metabolic reprogramming
por: Zhang, Xiaodong, et al.
Publicado: (2018) -
YAP and TAZ in Lung Cancer: Oncogenic Role and Clinical Targeting
por: Lo Sardo, Federica, et al.
Publicado: (2018) -
The Telluride YAP/TAZ and TEAD Workshop: A Small Meeting with a Big Impact
por: Weinberg, Guy L., et al.
Publicado: (2023)